Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.22%0700.HK-6.09%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.14%ORCL-0.97%3988.HK-0.04%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.27%0857.HK-1.46%UNH-10.21%1288.HK-1.27%PM-0.85%0005.HK-1.87%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.66%AUDUSD-1.51%EURAUD+1.03%AUDCHF-1.00%AUDNZD-0.98%AUDCAD-0.97%GBPAUD+0.96%GBPJPY-0.71%NZDJPY-0.71%CADJPY-0.70%EURJPY-0.67%CHFJPY-0.66%AUDSGD-0.63%AUDDKK-0.58%USDCAD+0.55%USDCHF+0.53%GBPUSD-0.53%NZDUSD-0.53%EURUSD-0.50%AUDNOK-0.47%GBPTRY+0.41%NZDMXN+0.39%USDMXN+0.32%GBPHKD+0.32%USDZAR+0.30%GBPMXN-0.28%USDTHB+0.25%EURZAR+0.24%GBPZAR+0.22%USDTRY+0.21%USDJPY-0.18%CHFNOK+0.17%USDILS+0.16%USDNOK+0.15%USDCNH-0.13%NOKJPY-0.11%CHFSEK+0.10%EURNOK+0.10%EURCNH-0.10%USDPLN+0.09%USDSEK+0.09%NZDSGD+0.09%GBPSGD-0.07%EURHKD-0.06%USDDKK+0.05%EURGBP+0.05%EURCAD+0.05%EURSGD-0.05%PLNJPY-0.05%SGDJPY+0.05%EURSEK+0.04%EURCZK+0.04%USDCOP-0.04%EURCHF+0.04%EURPLN+0.04%EURNZD+0.03%NZDCHF-0.03%CADCHF-0.02%CHFSGD+0.02%USDHKD-0.01%GBPCHF-0.01%USDSGD+0.01%GBPCAD-0.01%NZDCAD0.00%GBPNZD0.00%EURDKK0.00%W1-0.76%XNGUSD-0.61%C1-0.55%UKOIL+0.52%S1-0.39%USOIL+0.32%XAUUSD+0.24%GAUUSD+0.24%XPTUSD-0.22%XAGUSD+0.20%GAGUSD+0.20%COTTON+0.15%BTCUSD-3.51%ETHUSD+57.77%USDTUSD-0.02%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.77%ZECUSDT-6.76%XMRUSDT-1.71%DOGEUSD+55.95%LINKUSD-3.40%XLMUSD-3.79%BCHUSDT-3.59%LTCUSD+47.50%UNIUSD-3.05%SUIUSD-3.20%TONUSD+59.18%HBARUSDT-5.05%TAOUSDT-3.41%AAVEUSD-3.74%ONDOUSDT-5.51%ICPUSDT-2.22%DOTUSDT-3.90%WLDUSDT-3.57%ARBUSDT-5.68%ATOMUSDT-2.50%INJUSDT-7.97%STXUSDT-3.10%PYTHUSDT-0.76%TIAUSDT-3.37%FETUSDT-4.46%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.56%OPUSDT-3.90%IOTAUSDT-2.66%POLUSDT-2.10%WIFUSDT-2.98%AXSUSDT-2.91%EOSUSDT-4.24%IMXUSDT-3.36%FARTCOINUSDT-6.54%GALAUSDT-2.38%DYDXUSDT-2.63%ORDIUSDT-2.62%NOTUSDT+0.86%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.22%0700.HK-6.09%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.14%ORCL-0.97%3988.HK-0.04%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.27%0857.HK-1.46%UNH-10.21%1288.HK-1.27%PM-0.85%0005.HK-1.87%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.66%AUDUSD-1.51%EURAUD+1.03%AUDCHF-1.00%AUDNZD-0.98%AUDCAD-0.97%GBPAUD+0.96%GBPJPY-0.71%NZDJPY-0.71%CADJPY-0.70%EURJPY-0.67%CHFJPY-0.66%AUDSGD-0.63%AUDDKK-0.58%USDCAD+0.55%USDCHF+0.53%GBPUSD-0.53%NZDUSD-0.53%EURUSD-0.50%AUDNOK-0.47%GBPTRY+0.41%NZDMXN+0.39%USDMXN+0.32%GBPHKD+0.32%USDZAR+0.30%GBPMXN-0.28%USDTHB+0.25%EURZAR+0.24%GBPZAR+0.22%USDTRY+0.21%USDJPY-0.18%CHFNOK+0.17%USDILS+0.16%USDNOK+0.15%USDCNH-0.13%NOKJPY-0.11%CHFSEK+0.10%EURNOK+0.10%EURCNH-0.10%USDPLN+0.09%USDSEK+0.09%NZDSGD+0.09%GBPSGD-0.07%EURHKD-0.06%USDDKK+0.05%EURGBP+0.05%EURCAD+0.05%EURSGD-0.05%PLNJPY-0.05%SGDJPY+0.05%EURSEK+0.04%EURCZK+0.04%USDCOP-0.04%EURCHF+0.04%EURPLN+0.04%EURNZD+0.03%NZDCHF-0.03%CADCHF-0.02%CHFSGD+0.02%USDHKD-0.01%GBPCHF-0.01%USDSGD+0.01%GBPCAD-0.01%NZDCAD0.00%GBPNZD0.00%EURDKK0.00%W1-0.76%XNGUSD-0.61%C1-0.55%UKOIL+0.52%S1-0.39%USOIL+0.32%XAUUSD+0.24%GAUUSD+0.24%XPTUSD-0.22%XAGUSD+0.20%GAGUSD+0.20%COTTON+0.15%BTCUSD-3.51%ETHUSD+57.77%USDTUSD-0.02%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.77%ZECUSDT-6.76%XMRUSDT-1.71%DOGEUSD+55.95%LINKUSD-3.40%XLMUSD-3.79%BCHUSDT-3.59%LTCUSD+47.50%UNIUSD-3.05%SUIUSD-3.20%TONUSD+59.18%HBARUSDT-5.05%TAOUSDT-3.41%AAVEUSD-3.74%ONDOUSDT-5.51%ICPUSDT-2.22%DOTUSDT-3.90%WLDUSDT-3.57%ARBUSDT-5.68%ATOMUSDT-2.50%INJUSDT-7.97%STXUSDT-3.10%PYTHUSDT-0.76%TIAUSDT-3.37%FETUSDT-4.46%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.56%OPUSDT-3.90%IOTAUSDT-2.66%POLUSDT-2.10%WIFUSDT-2.98%AXSUSDT-2.91%EOSUSDT-4.24%IMXUSDT-3.36%FARTCOINUSDT-6.54%GALAUSDT-2.38%DYDXUSDT-2.63%ORDIUSDT-2.62%NOTUSDT+0.86%RONINUSDT-2.92%
ET

Edgewise Therapeutics, Inc. (EWTX)

NASDAQ • Healthcare

$41.37
-$0.67 (-1.6%)
Market closed

Last close at November 18, 2026 at 21:00 UTC

Open$42.32
Day Range$40.33 - $42.37
Avg. Volume (3M)1.6M
Market Cap$4.4B
P/E Ratio4.5
52 Week Range
$19.76$48.78

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
$1B
EPS (TTM)
$9.25
ROA (TTM)
56.72%
Current Ratio
12.3

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+8.0%Q2 2026-$0.46
-13.3%Q3 2026-$0.53
+1914.0%Q4 2026$9.65

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +1914.0%

Edgewise Therapeutics’ preliminary results for the third fiscal quarter of 2026, reported November 4, 2026, centered on ongoing investment in its muscle-disease small‑molecule programs, including EDG-5506, with operating income at -$46.1 million and operating cash flow at -$77.2 million. Consensus for the next period calls for EPS of -$0.48 on revenue of $9.6 million.

View full earnings history

About Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. is a NASDAQ-listed biotechnology company focused on small-molecule medicines for muscle disease. In qualitative terms, it is an early-stage healthcare developer, and its lead program is EDG-5506, an orally administered compound being studied for dystrophinopathies and other genetically defined muscle conditions.

Name
Edgewise Therapeutics, Inc.
CEO
Kevin Koch
Industry
Healthcare
Year Founded
2017
Employees
133

Today's Snapshot

AI-generated

EWTX closed 1.6% lower at 41.37, in line with a weaker sector. Trading was lighter than usual, with volume about two-fifths of its usual level.

Trading Volume

Below 10d avg (2.1M)

849.6K

vs S&P 500 Today

Underperforming Market

-1.33%

Updated: November 18, 2026 at 21:14 UTC

Technical Indicators

3 Buy2 Neutral3 Sell
EWTX is technically neutral, with momentum and oscillators sitting near midpoint levels and a modestly positive MACD that is offset by weak trend strength as shown by ADX. The stock trades around short- and medium-term averages while remaining above its 200-day moving average, which suggests longer-term support even as near-term direction is uncertain. Volatility is moderate and on-balance volume is not decisively directional, so signals conflict rather than converge. Technical takeaway: Neutral technical posture.
All signals
  • EMA (5 indicators)$36.37 - $43.27
    Sell
  • RSI (14)48.16
    Neutral
  • Stochastic %K (14, 3, 3)46.88
    Neutral
  • MACD Level (12, 26)1.05
    Buy
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.